Email the author Comparison Between The Effect of Clove, Filter and Biomass Cigarette Smoke to The Lung Function of COPD Patients at Harum Melati Pringsewu Clinic Lampung Province, Period January 2013-January 2020
Abstract
Method: This research is aquantitative method with descriptive analytic and retrospective approach. The samples were 203 COPD patients taken from medical records January 2013-January 2020 at Harum Melati Pringsewu Clinic Lampung Province with statistical test use Analysis Varians (ANOVA) technique.
Results: From the characteristics based on type of COPD smoke exposure were clove smokers 127 people (62.6%), filter smokers 3 people (1.5%) and biomass users 73 people (36.0%). The mean lung function COPD patients based on type of smoke exposure were 127 people with clove smokers with average lung function value 55.03%, the lowest value 12.20% and the highest 121.50%. Filter smokers of 3 people with average lung function value 75.07%, the lowest value was 67.00% and the highest 81.41%. Biomass users 73 people with average lung function value 56.91%, the lowest value 19.50% and the highest 149.13%. Comparison the effect clove cigarettes smoke, filter cigarettes and biomass on the pulmonary function of COPD patients obtained P=0.319.
Conclusion: There is a decrease lung function in clove smokers, filter smokers and biomass users in COPD patients but not statistically significant difference.
Keywords
Full Text:
PDF (Bahasa Indonesia)References
GOLD, Pocket Guide to COPD Diagnosis. Management and prevention: a guide for healthcare professionals. Sydney: Global Initiative for Chronic Obstructive Lung Disease Inc; 2019
Kementerian Kesehatan Republik Indonesia. Riset kesehatan dasar [Internet]. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia; 2014 [cited 2020 Jan 14]. Available from: www.pusdatin.kemkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf
Soemarwoto RA, Mustofa S, Sinaga F, Rusmini H, Morfi CW, Febriani N. Hubungan Penyakit Paru Obstruksi Kronik (PPOK) dengan Indeks Massa Tubuh (IMT) di Klinik Harum Melati Pringsewu tahun 2016-2017. JK Unila. 2019;3(1):73-7.
Gershon A, Hwee J, Victor JC, Wilton A, Wu R, Day A, et all. Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012. Thorax. 2015;70(2):121-6.
Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally?. Chest. 2010;138(1):3-6.
López-Campos JL, Fernández-Villar A, Calero-Acuña C, Represas-Represas C, López-Ramírez C, Fernández VL, Casamor R. Occupational and biomass exposure in COPD: results of a cross-sectional analysis of the on-sint study. Archivos de Bronconeumología (English Edition). 2017;53(1):7-12.
Ramírez-Venegas A, Sansores RH, Quintana-Carrillo RH, Velázquez-Uncal M, Hernandez-Zenteno RJ, Sánchez-Romero C, et all. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am J Respir Crit Care Med. 2014;190(9):996-1002.
Khurana S, Ravi A, Sutula J, Milone R, Williamson R, Plumb J, et all. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med. 2014;108(12):1761-70.
Peraturan Pemerintah Repoblik Indonesia No. 109 tahun 2012 tentang pengamanan bahan yang mengandung zat adiktif berupa produk tembakau bagi kesehatan. Jakarta: Sekretaris Negara. 2012 [cited 2020 Jan 14]. Available from: https://jdih.setkab.go.id/PUUdoc/173643/PP1092012.pdf.
TSC-IAKMI. Bunga rampai fakta tembakau dan permasalahannya di Indonesia. Jakarta: Tobacco Control Center - Ikatan Ahli Kesehatan Masyarakat Indonesia; 2013. p73-8.
World Health Organization and Research for International Tobacco Control. WHO report on the global tobacco epidemic. the mpower package. World Health Organization; 2011 [cited 2020 Jan 14]. Available from: https://www.who.int/teams/health-promotion/tobacco-control/who-report-on-the-global-tobacco-epidemic-2019.
Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Anto JM, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(3):542-6.
Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C, et all. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med. 2006;173(4):393-7.
Alsagaff H, Mangunnegoro H, Amin M, Yunus F, Bernsten RS, Johnson L. Reference spirometric values of healthy Indonesian school children and working adults, using equipment and methods that meet ATS recommendations. Airlangga University Press. 1993;12:3-18.
Salami RS, dkk. Keselamatan dan Kesehatan Lingkungan Kerja. Yogyakarta: Gajah Mada University Press; 2016. Hal. 209
Elassal G, Elsheikh M, Zeid AG. Assessment of depression and anxiety symptoms in chronic obstructive pulmonary disease patients: A case–control study. Egyptian J Chest Dis Tuberc. 2014;63(3):575-82.
Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et all. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229-34.
MMannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-73.
Yohannes AM. Management of anxiety and depression in patients with COPD. Expert review of respiratory medicine;2008. 2(3), pp.337-347.
Romieu I, Riojas-Rodriguez H, Marrón-Mares AT, Schilmann A, Perez-Padilla R, Masera O. Improved biomass stove intervention in rural Mexico: Impact on the respiratory health of women. Am J Respir Crit Care Med. 2009;180(7):649-56.
Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK and DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010;65:480-85
NNg TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60-7.
Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et all. Prevalence and correlations with depression, anxiety, and other features in out patients with chronic obstructive pulmonary disease in China:A cross-sectional case control study. BMC pulmonary medicine. 2012;12(1):53.
Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2):176-83.
Guyton AC, Hall JE. Buku ajar-Fisiologi kedokteran (Eds. 11) (Irawati, Dian Ramadhani, Fara Indriyani, Frans Dany, Imam Nuryanto, Srie Sisca Prima Rianti, Titiek Resmisari & Y. Joko Suyono, Penerjemah). Jakarta: EGC. 2008. p435-46.
MUkromah A, Andhini D, Fitri EY. Pengaruh metode pursed lips breathing terhadap Arus Puncak Ekspirasi pada pasien dengan Penyakit Paru Obstruktif Kronik. In Proceeding Seminar Nasional Keperawatan 2019. 2019;5(1):118-25.
Oni JW. Hubungan Antara Derajat Merokok dengan Bronkitis Kronik di BBKPM Surakarta Tahun 2012 (skripsi). 2012 [cited 2020 Mar 5]. Available from: http://eprints.uns.ac.id/22569/18/File_2_Naskah_Publikasi_Ilmiah.pdf.
Nisa Binti Saleh K. Prevalensi penderita Penyakit Paru Obstruksi Kronis (PPOK) dengan riwayat merokok di Rumah Sakit Umum Pusat Haji Adam Malik (RSUP HAM) Medan periode Januari 2009–Desember 2009 (student papers). 2010 [cited 2020 Feb 8]. Available from: http://repository.usu.ac.id/handle/123456789/21398.
Salawati L. Hubungan merokok dengan derajat PENYAKIT PARU OBSTRUKSI KRONIK. Jurnal Kedokteran Syiah Kuala. 2016;16(3):165-9.
Rachmawati A, Darundiati YH, Dewanti NA. Gambaran kejadian gangguan fungsi paru pada pekerja pengasapan ikan di Bandarharjo Semarang. Jurnal Kesehatan Masyarakat (e-Journal). 2018;6(6):32-40.
Basuki SW, Nilawati DD. Pengaruh merokok terhadap faal paru. Biomedika. 2011;3(2).
SUkmawati AM. Perbandingan nilai Forced Expiratory Flow pada perokok dan bukan perokok. J Respir Indo. 2016;36(3):167-74.
MEngkidi D. Gangguan fungsi paru dan faktor-faktor yang mempengaruhinya pada karyawan PT. Semen Tonasa Pangkep Sulawesi Selatan (disertasi). 2006 [cited 2020 Feb 8]. Available from: http://eprints.undip.ac.id/15485/.
Boskabadi MH, Dehghani H, Esmaeilzadeh M. Pulmonary function tests and their reversibility in smokers. NRITLD. 2003; 2(8): 23-30.
Ukoli CO, Joseph DE, Durosinmi MA. Peak expiratory flow rate in cigarette smokers. Highl Med Res J. 2002;1(2):36-7.
Ria N. Hubungan kadar Karbonmoksida (CO) ekspirasi dengan fungsi paru pada perokok, bekas perokok dan bukan perokok di RSUP HAM Medan, Sumatera Utara (tesis). 2019 [cited 2020 Feb8]. Available from: https://repositori.usu.ac.id.
Reilly J, Silverman E, & Shapiro S. Chronic Obstructive Pulmonary Disease. In J. Lascalzo, Harrison's Pulmonary and Critical Care Medicine (17th ed.). 2008, pp. 178-189. New York: McGrawHill Medical.
PDPI. PPOK (penyakit paru obstruktif kronik) diagnosis dan penatalaksanaan. Perhimpunan Dokter Paru Indonesia. Jakarta. 2011:8-10.
DOI: https://doi.org/10.36497/jri.v41i1.153
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Retno Ariza S Soemarwoto, Hetti Rusmini, Fransisca Sinaga, Agus Dwi Susanto, Arif Widiyantoro
INDEXING & PARTNER
| Jurnal Respirologi Indonesia pISSN: 0853-7704 - eISSN: 2620-3162 Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia Phone: +62-21-2247-4845 Email: editor@jurnalrespirologi.org |  An official publication by the Indonesian Society of Respirology (ISR) |
 Creative Commons Attribution-ShareAlike 4.0 International License Statcounter |